Dangers of Unnecessary IV Antibiotics
Introduction to Risks
- The use of intravenous antibiotics when not medically necessary exposes patients to serious risks, including life-threatening complications, without providing any clinical benefit 1, 2
Antimicrobial Resistance and Superinfection
- Inappropriate antibiotic use, including using them when none are needed, affects 30-50% of all antibiotic prescriptions and is a key driver of antimicrobial resistance, with 1.3 million deaths globally in 2019 attributed to antimicrobial resistance 1, 2
- The COVID-19 pandemic demonstrated the danger of unnecessary antibiotic use, with most hospitalized patients receiving antibiotics despite SARS-CoV-2 being viral, further exacerbating the selection of multidrug-resistant strains 1, 2
Adverse Events and Infections
- One in five patients taking antibiotics will develop an adverse event requiring a doctor or emergency room visit, with C. difficile infection being among the most serious, occurring even with short courses of antibiotics 3
- Allergic reactions, ranging from mild rash to life-threatening anaphylaxis, occur with all IV antibiotics, requiring immediate medical intervention and can be fatal 3
Organ-Specific Toxicity
- IV aminoglycosides combined with other nephrotoxic agents substantially increase the risk of kidney injury, highlighting the need for careful monitoring and dosing 4, 5
Clinical Pitfalls and Future Treatment Options
- Prescribing IV antibiotics for viral respiratory tract infections is a common and dangerous pitfall, where large quantities are prescribed unnecessarily, eliminating treatment options for future infections 6, 7
- The clinical benefit of IV antibiotics must always be weighed against the substantial risks, and when no bacterial infection is present, the risk-benefit ratio is entirely unfavorable 6, 7